Gilead tie-up ,Big Pharma confidence,massive upside if trials OKNurix Therapeutics, Inc.BATS:NRIXramkdlr 🧪 Pipeline Progress (as of latest update): NX-2127 & NX-5948 in Phase 1 🔬 NX-1607: Promising early clinical data in solid tumors Multiple preclinical programs in immuno-oncology and autoimmune space Down ~80% from highs (2021 biotech bubble burst 😬) Consolidating near lows — potential bottom fishing zone 🐟 High short interest = possible squeeze setup 🔥 Speculative high-reward biotech. Great long-term potential if pipeline delivers. Suitable for risk-tolerant investors only. Not for the faint-hearted 🧠⚡